Importance A low-burden electronic health record (EHR) workflow has been devised to systematize the collection and validation of 6 key diabetes…
Background: The benefits of Continuous Glucose Monitoring (CGM) on glycemic management have been demonstrated in numerous studies; however, widespread uptake…
Context COVID-19 morbidity and mortality are increased in type 1 diabetes (T1D), but few data focus on age-based outcomes. Objective…
Background: We describe the utilization of telemedicine visits (video or telephone) across the type 1 diabetes (T1D) Exchange Quality Improvement Collaborative…
Medical advances, including the development of new medications and advanced technologies, have the potential to improve outcomes for youths and…
Despite immense strides in therapeutic advances, clinical outcomes continue to be less than ideal for people with type 1 diabetes.…
Insulin pump therapy in pediatric type 1 diabetes has been associated with better glycemic control than multiple daily injections. However,…
Health care inequities among racial and ethnic groups remain prevalent. For people with type 1 diabetes who require increased medical…
Continuous glucose monitoring (CGM) use is associated with improved A1C outcomes and quality of life in adolescents and young adults…
People with coronavirus disease 2019 (COVID-19) and preexisting type 1 diabetes (T1D) are at high risk of diabetes-related outcomes such…